{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:02:57Z","timestamp":1789833777786,"version":"4.0.1"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.micpath.2026.108780","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:08:33Z","timestamp":1787008113000},"page":"108780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The miRNA-virus axis in RNA virus infections: Mechanisms, therapeutic targeting, and systems biology approaches"],"prefix":"10.1016","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0922-0142","authenticated-orcid":false,"given":"Dakshina M.","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leela Kakithakara","family":"Vajravelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul Harikumar","family":"Lathakumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poornima Baskar","family":"Vimala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishnupriya","family":"Paneerselvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayaprakash","family":"Thulukanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2026.108780_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.17","article-title":"Epidemiological characteristics of human-infective RNA viruses","volume":"5","author":"Woolhouse","year":"2018","journal-title":"Sci. Data"},{"issue":"14","key":"10.1016\/j.micpath.2026.108780_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01031-17","article-title":"Complexities of viral mutation rates","volume":"92","author":"Peck","year":"2018","journal-title":"J. Virol."},{"issue":"7446","key":"10.1016\/j.micpath.2026.108780_bib3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"issue":"10127","key":"10.1016\/j.micpath.2026.108780_bib4","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.micpath.2026.108780_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V'kovski","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"15","key":"10.1016\/j.micpath.2026.108780_bib6","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.1128\/JVI.00191-09","article-title":"Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes","volume":"83","author":"Rotman","year":"2009","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.micpath.2026.108780_bib7","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1007\/s00018-016-2299-6","article-title":"Mechanisms of viral mutation","volume":"73","author":"Sanju\u00e1n","year":"2016","journal-title":"Cell. Mol. Life Sci. : CMLS"},{"issue":"10","key":"10.1016\/j.micpath.2026.108780_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008271","article-title":"Viral quasispecies","volume":"15","author":"Domingo","year":"2019","journal-title":"PLoS Genet."},{"issue":"1","key":"10.1016\/j.micpath.2026.108780_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/ijms27010147","article-title":"Targeting host dependency factors: a paradigm shift in antiviral strategy against RNA viruses","volume":"27","author":"Yang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.micpath.2026.108780_bib10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.molmed.2016.11.003","article-title":"MicroRNA regulation of RNA virus replication and pathogenesis","volume":"23","author":"Trobaugh","year":"2017","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.micpath.2026.108780_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.micpath.2026.108780_bib12","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/cbin.11565","article-title":"Host-virus interaction and viral evasion","volume":"45","author":"Strumillo","year":"2021","journal-title":"Cell Biol. Int."},{"issue":"20","key":"10.1016\/j.micpath.2026.108780_bib13","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1038\/sj.emboj.7600385","article-title":"MicroRNA genes are transcribed by RNA polymerase II","volume":"23","author":"Lee","year":"2004","journal-title":"EMBO J."},{"issue":"24","key":"10.1016\/j.micpath.2026.108780_bib14","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1101\/gad.1262504","article-title":"The Drosha-DGCR8 complex in primary microRNA processing","volume":"18","author":"Han","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.micpath.2026.108780_bib15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.micpath.2026.108780_bib16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.emboj.7600491","article-title":"Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha","volume":"24","author":"Zeng","year":"2005","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.micpath.2026.108780_bib17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1042\/BST20140142","article-title":"Regulation of miRNA strand selection: follow the leader?","volume":"42","author":"Meijer","year":"2014","journal-title":"Biochem. Soc. Trans."},{"issue":"4","key":"10.1016\/j.micpath.2026.108780_bib18","first-page":"62","article-title":"Partners in silencing: decoding the mammalian argonaute interactome","volume":"11","author":"Narasimhan","year":"2025","journal-title":"Noncod. RNA"},{"issue":"3","key":"10.1016\/j.micpath.2026.108780_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1627","article-title":"microRNA strand selection: unwinding the rules","volume":"12","author":"Medley","year":"2021","journal-title":"Wiley Interdiscip. Rev. RNA"},{"issue":"19","key":"10.1016\/j.micpath.2026.108780_bib20","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.jmb.2013.03.007","article-title":"The role of miRNAs in regulating gene expression networks","volume":"425","author":"Gurtan","year":"2013","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.micpath.2026.108780_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ni.2537","article-title":"MicroRNAs as mediators of viral evasion of the immune system","volume":"14","author":"Cullen","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.micpath.2026.108780_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.micro.112408.134243","article-title":"Viruses, microRNAs, and host interactions","volume":"64","author":"Skalsky","year":"2010","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2026.108780_bib23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev-immunol-020711-075013","article-title":"microRNA regulation of inflammatory responses","volume":"30","author":"O'Connell","year":"2012","journal-title":"Annu. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.micpath.2026.108780_bib24","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3390\/v2071382","article-title":"Targeting microRNA-122 to treat hepatitis C virus infection","volume":"2","author":"Jopling","year":"2010","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.micpath.2026.108780_bib25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2008.06.010","article-title":"Regulation of the hepatitis C virus genome replication by miR-199a","volume":"50","author":"Murakami","year":"2009","journal-title":"J. Hepatol."},{"issue":"17","key":"10.1016\/j.micpath.2026.108780_bib26","doi-asserted-by":"crossref","first-page":"8849","DOI":"10.1128\/JVI.00456-10","article-title":"Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells","volume":"84","author":"Song","year":"2010","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.micpath.2026.108780_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12929-019-0614-x","article-title":"Role of microRNAs in antiviral responses to dengue infection","volume":"27","author":"Wong","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.micpath.2026.108780_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1742-4690-5-117","article-title":"Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication","volume":"5","author":"Ahluwalia","year":"2008","journal-title":"Retrovirology"},{"key":"10.1016\/j.micpath.2026.108780_bib29","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3389\/fimmu.2014.00578","article-title":"MicroRNA-146a: a dominant, negative regulator of the innate immune response","volume":"5","author":"Saba","year":"2014","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.micpath.2026.108780_bib30","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nsmb.2296","article-title":"The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC","volume":"19","author":"Fabian","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.micpath.2026.108780_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semcdb.2022.11.007","article-title":"Viral miRNA regulation of host gene expression","volume":"146","author":"Diggins","year":"2023","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.micpath.2026.108780_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.802149","article-title":"The influence of host miRNA binding to RNA within RNA viruses on virus multiplication","volume":"12","author":"Lei","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"10.1016\/j.micpath.2026.108780_bib33","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2174\/1381612826666200109181238","article-title":"Viral MicroRNAs: interfering the interferon signaling","volume":"26","author":"Ahmad","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.micpath.2026.108780_bib34","first-page":"249","article-title":"MicroRNA in immune regulation","volume":"410","author":"Wu","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"8","key":"10.1016\/j.micpath.2026.108780_bib35","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ni.f.209","article-title":"MicroRNAs: new regulators of immune cell development and function","volume":"9","author":"Baltimore","year":"2008","journal-title":"Nat. Immunol."},{"issue":"33","key":"10.1016\/j.micpath.2026.108780_bib36","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"10","key":"10.1016\/j.micpath.2026.108780_bib37","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1101\/gad.1793309","article-title":"The role of RNAi and microRNAs in animal virus replication and antiviral immunity","volume":"23","author":"Umbach","year":"2009","journal-title":"Gene Dev."},{"issue":"7","key":"10.1016\/j.micpath.2026.108780_bib38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.it.2008.04.004","article-title":"microRNAs and the immune response","volume":"29","author":"Lindsay","year":"2008","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.micpath.2026.108780_bib39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s13237-021-00378-9","article-title":"Regulation of autophagy by miRNAs in human diseases","volume":"64","author":"Roy","year":"2021","journal-title":"Nucleus (Calcutta)."},{"issue":"6","key":"10.1016\/j.micpath.2026.108780_bib40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.chom.2008.05.002","article-title":"Viral and cellular microRNAs as determinants of viral pathogenesis and immunity","volume":"3","author":"Gottwein","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micpath.2026.108780_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.coi.2018.06.010","article-title":"Antiviral RNA interference in mammals","volume":"54","author":"Ding","year":"2018","journal-title":"Curr. Opin. Immunol."},{"issue":"20","key":"10.1016\/j.micpath.2026.108780_bib42","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1128\/MCB.00871-14","article-title":"Virus meets host microRNA: the destroyer, the booster, the hijacker","volume":"34","author":"Guo","year":"2014","journal-title":"Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.micpath.2026.108780_bib43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nri.2016.40","article-title":"MicroRNAs as regulatory elements in immune system logic","volume":"16","author":"Mehta","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.micpath.2026.108780_bib44","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.1093\/nar\/gky029","article-title":"Positive-sense RNA viruses reveal the complexity and dynamics of the cellular and viral epitranscriptomes during infection","volume":"46","author":"McIntyre","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.micpath.2026.108780_bib45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13059-023-03110-9","article-title":"Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells","volume":"24","author":"Liao","year":"2023","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.micpath.2026.108780_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109839","article-title":"Role of miR-2392 in driving SARS-CoV-2 infection","volume":"37","author":"McDonald","year":"2021","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.micpath.2026.108780_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41544-018-0004-7","article-title":"microRNAs in viral acute respiratory infections: immune regulation, biomarkers, therapy, and vaccines","volume":"1","author":"Leon-Icaza","year":"2019","journal-title":"ExRNA"},{"issue":"8","key":"10.1016\/j.micpath.2026.108780_bib47","doi-asserted-by":"crossref","first-page":"9405","DOI":"10.1007\/s00210-025-03893-7","article-title":"MicroRNAs in HIV infection: dual regulators of viral replication and host immunity","volume":"398","author":"Mansour","year":"2025","journal-title":"N. Schmied. Arch. Pharmacol."},{"key":"10.1016\/j.micpath.2026.108780_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.azn.2025.01.002","article-title":"Critical role of cellular microRNAs in virus infection: decades of progress","author":"Han","year":"2025","journal-title":"Animal. Zoonoses"},{"issue":"2","key":"10.1016\/j.micpath.2026.108780_bib50","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/med.22073","article-title":"A comprehensive overview on the crosstalk between microRNAs and viral pathogenesis and infection","volume":"45","author":"Bahojb Mahdavi","year":"2025","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.micpath.2026.108780_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1734182","article-title":"Non-coding RNAs in the viral host-pathogen interaction: molecular regulation and therapeutic potential","volume":"15","author":"Yamin","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108780_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-70974-7","article-title":"The impact of host microRNAs on the development of conserved mutations of SARS-CoV-2","volume":"14","author":"Ghaemi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108780_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1567459","article-title":"Interferon and immunity: the role of microRNA in viral evasion strategies","volume":"16","author":"Bayat","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108780_bib54","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41435-024-00283-6","article-title":"The ability of microRNAs to regulate the immune response in ischemia\/reperfusion inflammatory pathways","volume":"25","author":"Artimovi\u010d","year":"2024","journal-title":"Gene Immun."},{"issue":"1","key":"10.1016\/j.micpath.2026.108780_bib55","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2341144","article-title":"Viral strategies to antagonize the host antiviral innate immunity: an indispensable research direction for emerging virus-host interactions","volume":"13","author":"Chen","year":"2024","journal-title":"Emerg. Microb. Infect."},{"issue":"22","key":"10.1016\/j.micpath.2026.108780_bib56","doi-asserted-by":"crossref","first-page":"12397","DOI":"10.1093\/nar\/gkad1000","article-title":"Binding of microRNA-122 to the hepatitis C virus 5' untranslated region modifies interactions with poly(C) binding protein 2 and the NS5B viral polymerase","volume":"51","author":"Scott","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.micpath.2026.108780_bib57","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.1038\/s41467-021-27177-9","article-title":"A structured RNA motif locks Argonaute2:miR-122 onto the 5' end of the HCV genome","volume":"12","author":"Gebert","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.micpath.2026.108780_bib58","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4161\/rna.25137","article-title":"miR-122 and the hepatitis C RNA genome: more than just stability","volume":"10","author":"Li","year":"2013","journal-title":"RNA Biol."},{"issue":"2","key":"10.1016\/j.micpath.2026.108780_bib59","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/biom16020283","article-title":"MicroRNAs in long COVID: key regulators, biomarkers, and therapeutic targets of Post-SARS-CoV-2 sequelae","volume":"16","author":"Makki","year":"2026","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.micpath.2026.108780_bib60","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12964-023-01345-4","article-title":"SARS-CoV-2 primed platelets-derived microRNAs enhance NETs formation by extracellular vesicle transmission and TLR7\/8 activation","volume":"21","author":"Liao","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.micpath.2026.108780_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2026.151332","article-title":"Host-derived miRNAs as novel regulators of porcine reproductive and respiratory syndrome virus replication: mechanistic insights and therapeutic potentials","volume":"354","author":"Zhang","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"issue":"Pt A","key":"10.1016\/j.micpath.2026.108780_bib62","article-title":"MicroRNA-155 and antiviral immune responses","volume":"101","author":"Jafarzadeh","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.micpath.2026.108780_bib63","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/15476286.2021.1880756","article-title":"microRNA-21: a key modulator in oncogenic viral infections","volume":"18","author":"He","year":"2021","journal-title":"RNA Biol."},{"key":"10.1016\/j.micpath.2026.108780_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110448","article-title":"Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19","volume":"146","author":"Roganovi\u0107","year":"2021","journal-title":"Med. Hypotheses"},{"issue":"10","key":"10.1016\/j.micpath.2026.108780_bib65","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s00705-021-05152-5","article-title":"The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection","volume":"166","author":"Hu","year":"2021","journal-title":"Arch. Virol."},{"issue":"5","key":"10.1016\/j.micpath.2026.108780_bib66","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s40265-021-01474-5","article-title":"MicroRNA mimics or inhibitors as antiviral therapeutic approaches against COVID-19","volume":"81","author":"Hum","year":"2021","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.micpath.2026.108780_bib67","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.3390\/pharmaceutics13122015","article-title":"Antisense oligonucleotide-based therapy of viral infections","volume":"13","author":"Tarn","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.micpath.2026.108780_bib68","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3390\/ph18070987","article-title":"Therapeutic approaches of viral gene silencing by small interfering RNA: strategies to prevent the emergence of antiviral resistant escape mutants","volume":"18","author":"Kang","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.micpath.2026.108780_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199314","article-title":"Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications","volume":"341","author":"Zahedipour","year":"2024","journal-title":"Virus Res."},{"key":"10.1016\/j.micpath.2026.108780_bib70","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3389\/fphar.2018.01090","article-title":"Generation of MicroRNA-34 sponges and tough decoys for the heart: developments and challenges","volume":"9","author":"Bernardo","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"7603","key":"10.1016\/j.micpath.2026.108780_bib71","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.micpath.2026.108780_bib72","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3390\/ijms25031469","article-title":"Trials and tribulations of MicroRNA therapeutics","volume":"25","author":"Seyhan","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108780_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1466337","article-title":"Composition of lipid nanoparticles for targeted delivery: application to mRNA therapeutics","volume":"15","author":"Vasileva","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2026.108780_bib74","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jconrel.2024.04.022","article-title":"Lipid nanoparticle-based strategies for extrahepatic delivery of nucleic acid therapies - challenges and opportunities","volume":"370","author":"Simonsen","year":"2024","journal-title":"J. Contr. Release : Off. J. Controll. Release Soc."},{"issue":"8","key":"10.1016\/j.micpath.2026.108780_bib75","article-title":"Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery","author":"Haque","year":"2024","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.micpath.2026.108780_bib76","article-title":"Recent advances in lipid nanoparticles: nucleic acid therapeutics and targeting strategies","volume":"43","author":"Sarmah","year":"2025","journal-title":"Small21"},{"key":"10.1016\/j.micpath.2026.108780_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115461","article-title":"Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids","volume":"215","author":"Bader","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.micpath.2026.108780_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1583992","article-title":"Engineered exosomes: a promising drug delivery platform with therapeutic potential","volume":"12","author":"Schwarz","year":"2025","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.micpath.2026.108780_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.cjprs.2025.05.001","article-title":"Recent advances in scalable exosome production: challenges and innovations","author":"Chen","year":"2025","journal-title":"Chinese J. Plastic Reconstruct. Surg."},{"issue":"2","key":"10.1016\/j.micpath.2026.108780_bib80","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/v17020239","article-title":"Adeno-associated virus vectors: principles, practices, and prospects in gene therapy","volume":"17","author":"Zwi-Dantsis","year":"2025","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.micpath.2026.108780_bib83","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.micpath.2026.108780_bib84","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3390\/ijms25031469","article-title":"Trials and tribulations of MicroRNA therapeutics","volume":"25","author":"Seyhan","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.micpath.2026.108780_bib114","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.micpath.2026.108780_bib85","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.micpath.2026.108780_bib86","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.molcel.2019.09.013","article-title":"Programmable inhibition and detection of RNA viruses using Cas13","volume":"76","author":"Freije","year":"2019","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.micpath.2026.108780_bib87","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","article-title":"Genome-scale CRISPR-mediated control of gene repression and activation","volume":"159","author":"Gilbert","year":"2014","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.micpath.2026.108780_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.preme.2025.100048","article-title":"CRISPR delivery systems for organ-specific targeting: advances and challenges","volume":"2","author":"Du","year":"2025","journal-title":"Precision Med. Eng."},{"issue":"2","key":"10.1016\/j.micpath.2026.108780_bib82","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/pharmaceutics16020248","article-title":"Different targeting ligands-mediated drug delivery systems for tumor therapy","volume":"16","author":"Yan","year":"2024","journal-title":"Pharmaceutics"},{"issue":"17\u201318","key":"10.1016\/j.micpath.2026.108780_bib88","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1089\/hum.2024.113","article-title":"Advances in MicroRNA therapeutics: from preclinical to clinical studies","volume":"35","author":"Brillante","year":"2024","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.micpath.2026.108780_bib89","article-title":"Expression of microRNAs in the detection and therapeutic roles of viral infections: mechanisms and applications","volume":"11","author":"Poudineh","year":"2025","journal-title":"J. Virus Erad."},{"key":"10.1016\/j.micpath.2026.108780_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2026.108346","article-title":"A review of targeting microRNAs as potential therapeutic strategies against respiratory viruses: current insights and future directions","volume":"213","author":"Jalili","year":"2026","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2026.108780_bib91","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7675","key":"10.1016\/j.micpath.2026.108780_bib92","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nature24049","article-title":"RNA targeting with CRISPR-Cas13","volume":"550","author":"Abudayyeh","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.micpath.2026.108780_bib93","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/nat.2018.0736","article-title":"GalNAc-siRNA conjugates: leading the way for delivery of RNAi therapeutics","volume":"28","author":"Springer","year":"2018","journal-title":"Nucleic Acid Therapeut."},{"key":"10.1016\/j.micpath.2026.108780_bib94","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"4","key":"10.1016\/j.micpath.2026.108780_bib95","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.mib.2009.06.003","article-title":"Virus-host interactions: from systems biology to translational research","volume":"12","author":"Peng","year":"2009","journal-title":"Curr. Opin. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2026.108780_bib96","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrg2918","article-title":"Network medicine: a network-based approach to human disease","volume":"12","author":"Barab\u00e1si","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.micpath.2026.108780_bib97","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/msb.2011.99","article-title":"Differential network biology","volume":"8","author":"Ideker","year":"2012","journal-title":"Mol. Syst. Biol."},{"issue":"1","key":"10.1016\/j.micpath.2026.108780_bib98","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome Biol."},{"issue":"5","key":"10.1016\/j.micpath.2026.108780_bib99","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrg.2018.4","article-title":"Integrative omics for health and disease","volume":"19","author":"Karczewski","year":"2018","journal-title":"Nat. Rev. Genet."},{"issue":"5","key":"10.1016\/j.micpath.2026.108780_bib100","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.micpath.2026.108780_bib101","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41576-019-0093-7","article-title":"Integrative single-cell analysis","volume":"20","author":"Stuart","year":"2019","journal-title":"Nat. Rev. Genet."},{"issue":"5","key":"10.1016\/j.micpath.2026.108780_bib102","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","article-title":"Single-cell multi-omics analysis of the immune response in COVID-19","volume":"27","author":"Stephenson","year":"2021","journal-title":"Nat. Med."},{"issue":"7865","key":"10.1016\/j.micpath.2026.108780_bib103","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41586-021-03570-8","article-title":"COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets","volume":"595","author":"Delorey","year":"2021","journal-title":"Nature"},{"issue":"D1","key":"10.1016\/j.micpath.2026.108780_bib104","first-page":"D148","article-title":"miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database","volume":"48","author":"Huang","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.micpath.2026.108780_bib105","doi-asserted-by":"crossref","first-page":"W244","DOI":"10.1093\/nar\/gkaa467","article-title":"miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology","volume":"48","author":"Chang","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.micpath.2026.108780_bib106","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1101\/gr.205146.116","article-title":"microRNA target prediction programs predict many false positives","volume":"27","author":"Pinz\u00f3n","year":"2017","journal-title":"Genome Res."},{"issue":"6","key":"10.1016\/j.micpath.2026.108780_bib107","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrg3920","article-title":"Machine learning applications in genetics and genomics","volume":"16","author":"Libbrecht","year":"2015","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.micpath.2026.108780_bib108","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.micpath.2026.108780_bib109","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/cimb47060470","article-title":"Integrating artificial intelligence in next-generation sequencing: advances, challenges, and future directions","volume":"47","author":"Athanasopoulou","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"issue":"5","key":"10.1016\/j.micpath.2026.108780_bib110","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrg3899","article-title":"High-throughput functional genomics using CRISPR-Cas9","volume":"16","author":"Shalem","year":"2015","journal-title":"Nat. Rev. Genet."},{"issue":"12","key":"10.1016\/j.micpath.2026.108780_bib111","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2217\/pgs.12.121","article-title":"The miRNA-drug resistance connection: a new era of personalized medicine using noncoding RNA begins","volume":"13","author":"Mishra","year":"2012","journal-title":"Pharmacogenomics"},{"issue":"10","key":"10.1016\/j.micpath.2026.108780_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076811","article-title":"microRNAs in circulation are altered in response to influenza A virus infection in humans","volume":"8","author":"Tambyah","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2026.108780_bib128","first-page":"16","article-title":"The relationship between microRNAs and COVID-19 complications","volume":"10","author":"Kebriaei","year":"2024","journal-title":"Noncod. RNA Res."},{"issue":"16","key":"10.1016\/j.micpath.2026.108780_bib129","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612767","article-title":"MiRNA-146a-A key player in immunity and diseases","volume":"24","author":"Gilyazova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.micpath.2026.108780_bib113","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.micpath.2026.108780_bib115","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.micpath.2026.108780_bib116","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1021\/acs.accounts.9b00368","article-title":"Lipid nanoparticle technology for clinical translation of siRNA therapeutics","volume":"52","author":"Kulkarni","year":"2019","journal-title":"Acc. Chem. Res."},{"issue":"12","key":"10.1016\/j.micpath.2026.108780_bib117","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"1","key":"10.1016\/j.micpath.2026.108780_bib118","first-page":"63","article-title":"miRNA-Based therapeutic strategies","volume":"1","author":"Ishida","year":"2013","journal-title":"Curr. Anesthesiol. Rep."},{"key":"10.1016\/j.micpath.2026.108780_bib119","article-title":"Recent advances in the development and clinical application of miRNAs in infectious diseases","author":"Nunes","year":"2024","journal-title":"Non-Cod. RNA Res."},{"issue":"3","key":"10.1016\/j.micpath.2026.108780_bib120","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3390\/ijms22031176","article-title":"Measurements methods for the development of MicroRNA-Based tests for cancer diagnosis","volume":"22","author":"Precazzini","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.micpath.2026.108780_bib121","doi-asserted-by":"crossref","DOI":"10.1155\/jimr\/5862241","article-title":"MicroRNAs in acute COVID-19 and long COVID: dysregulation, pathogenic roles, and clinical implications","volume":"2026","author":"Silva","year":"2026","journal-title":"J. Immunol. Res."},{"issue":"5","key":"10.1016\/j.micpath.2026.108780_bib122","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5501\/wjv.v12.i5.242","article-title":"Emerging perspectives on RNA virus-mediated infections: from pathogenesis to therapeutic interventions","volume":"12","author":"Mohanty","year":"2023","journal-title":"World J. Virol."},{"issue":"1","key":"10.1016\/j.micpath.2026.108780_bib123","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13073-019-0701-3","article-title":"Digital twins to personalize medicine","volume":"12","author":"Bj\u00f6rnsson","year":"2019","journal-title":"Genome Med."},{"key":"10.1016\/j.micpath.2026.108780_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2026.102652","article-title":"Small RNAs, big potential: engineering microRNA-based synthetic gene circuits","volume":"90","author":"Kundu","year":"2026","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.micpath.2026.108780_bib125","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3389\/fphar.2018.01090","article-title":"Generation of MicroRNA-34 sponges and tough decoys for the heart: developments and challenges","volume":"9","author":"Bernardo","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.micpath.2026.108780_bib126","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3390\/ijms25031739","article-title":"mRNA delivery: challenges and advances through polymeric soft nanoparticles","volume":"25","author":"Yousefi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.micpath.2026.108780_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102572","article-title":"Delivery strategies for RNA-targeting therapeutic nucleic acids and RNA-based vaccines against respiratory RNA viruses: IAV, SARS-CoV-2, RSV","volume":"36","author":"Maziec","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026005061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026005061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:18:06Z","timestamp":1789831086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401026005061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":129,"alternative-id":["S0882401026005061"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108780","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The miRNA-virus axis in RNA virus infections: Mechanisms, therapeutic targeting, and systems biology approaches","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108780"}}